Investor Stock List
Ranked #3,131 of 8,699 institutional investors

Palo Alto Investors LP

Palo Alto, CA

$632M
US stock portfolio at live prices · today −$7.9M (−1.23%)
Live prices, last trade 12:52 PM ET
Value at quarter end (Q3 2026)
$672M
Change from Q2 2026
−$51.6M (−7.13%)
Positions
48 · 3 new, 0 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$45.2M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
INSM 10.2%PTCT 7.94%ACAD 6.85%BMRN 6.17%MIRM 5.96%
StockSharesValue, live% of portfoliovs Q2 2026
INSM Insmed Incorporated443,645$64.3M10.2%Added +7%
PTCT PTC Therapeutics, Inc.875,349$50.2M7.94%Reduced −5%
ACAD Acadia Pharmaceuticals Inc.2,485,608$43.3M6.85%Reduced −13%
BMRN BioMarin Pharmaceutical Inc.642,455$39.0M6.17%Reduced −6%
MIRM Mirum Pharmaceuticals, Inc.387,314$37.6M5.96%Added +11%
BIIB Biogen Inc.132,918$33.1M5.24%Reduced −5%
UTHR United Therapeutics Corporation58,875$32.7M5.17%Reduced −6%
TRAX First Tracks Biotherapeutics, Inc.741,097$31.5M4.98%Added +23%
CDNA CareDx, Inc.424,601$30.0M4.75%Reduced −20%
IRON Disc Medicine, Inc.396,529$29.7M4.70%Reduced −5%
DYN Dyne Therapeutics, Inc.1,881,927$29.6M4.69%Added +14%
ANAB AnaptysBio, Inc.595,264$27.9M4.42%Reduced −1%
IOVA Iovance Biotherapeutics, Inc.3,471,456$24.4M3.86%Reduced −34%
RARE Ultragenyx Pharmaceutical Inc.710,029$11.8M1.86%Added +19%
CLDX Celldex Therapeutics, Inc.343,101$9.5M1.50%Reduced −14%
ANNX Annexon, Inc.2,811,222$8.8M1.40%Reduced −5%
TVTX Travere Therapeutics, Inc.158,946$7.7M1.22%Reduced −5%
BCAX Bicara Therapeutics Inc.689,344$6.1M0.96%Added +25%
AGIO Agios Pharmaceuticals, Inc.200,984$5.7M0.90%Reduced −6%
SNDX Syndax Pharmaceuticals, Inc.596,356$5.3M0.84%Reduced −31%
TSHA Taysha Gene Therapies, Inc.1,337,217$5.0M0.79%Reduced −4%
ALGN Align Technology, Inc.31,389$4.9M0.78%Unchanged
CMPX Compass Therapeutics, Inc.7,148,673$4.7M0.75%Added +23%
CAPR Capricor Therapeutics, Inc.548,071$4.3M0.68%Added +139%
ACRS Aclaris Therapeutics, Inc.1,156,396$4.0M0.63%Reduced −28%
EW Edwards Lifesciences Corporation33,640$3.5M0.55%Unchanged
NBIX Neurocrine Biosciences, Inc.18,117$2.8M0.44%Unchanged
ORKA Oruka Therapeutics, Inc.25,563$2.4M0.38%Reduced −24%
TARA Protara Therapeutics, Inc.1,035,964$2.3M0.37%New
STOK Stoke Therapeutics, Inc.84,631$2.3M0.36%Unchanged
SGMT Sagimet Biosciences Inc.250,000$2.2M0.36%Unchanged
VSTM Verastem, Inc.325,480$2.1M0.34%Added +5%
CTNM Contineum Therapeutics, Inc.220,226$1.9M0.31%New
XENE Xenon Pharmaceuticals Inc.47,902$1.8M0.28%Reduced −7%
XERS Xeris Biopharma Holdings, Inc.104,410$1.8M0.28%Unchanged
PYXS Pyxis Oncology, Inc.864,277$1.6M0.25%Unchanged
BNTX BioNTech SE19,614$1.6M0.25%Unchanged
HUM Humana Inc.3,985$1.6M0.25%Unchanged
CYTK Cytokinetics, Incorporated30,036$1.5M0.24%Reduced −7%
ANL Adlai Nortye Group Ltd.149,490$1.3M0.21%New
NUVB Nuvation Bio Inc.326,609$1.2M0.19%Unchanged
CMPS COMPASS Pathways plc115,616$942K0.15%Unchanged
MDGL Madrigal Pharmaceuticals, Inc.1,787$693K0.11%Unchanged
BCYC Bicycle Therapeutics plc188,351$549K<0.1%Reduced −7%
INSP Inspire Medical Systems, Inc.8,772$486K<0.1%Unchanged
EHTH eHealth, Inc.1,431,535$460K<0.1%Reduced −3%
ABEO Abeona Therapeutics Inc.108,865$266K<0.1%Unchanged
ALDX Aldeyra Therapeutics, Inc.155,709$131K<0.1%Unchanged